1-14 of 14
Mark G. Kris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5817: Single cell profiling of diffuse pleural mesothelioma reveals tumor cell plasticity and dynamic immune responses when exposed to platinum, pemetrexed and nivolumab

Michael Offin, Matthew Zatzman, Yonit Lavin, Jennifer L. Sauter, Nataly Naser Al Deen, Nicholas Ceglia, William D. Travis, Rania G. Aly, Andreas Rimner, Annemarie Shepherd, Charles B. Simone, Mark G. Kris, Michelle S. Ginsberg, Andrew Chow, Alvaro Quintanal-Villalonga, Sohrab P. Shah, Charles M. Rudin, Valerie W. Rusch, Prasad S. Adusumilli, Marjorie G. Zauderer
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 5817.
https://doi.org/10.1158/1538-7445.AM2025-5817
Published: 21 April 2025
View articletitled, Abstract 5817: Single cell profiling of diffuse pleural mesothelioma reveals tumor cell plasticity and dynamic immune responses when exposed to platinum, pemetrexed and nivolumab
Journal Articles

Abstract 6570: HLA genotyping and HLA-based clinical trial matching using MSK-IMPACT, a targeted next-generation sequencing assay

Monica F. Chen, Michael V. Gormally, Anne Marie Noronha, Kristalla Panageas, Maggie Reynolds, Kaelyn Kohlasch, Bryan Novak, Tatiana Kee-Velez, Nikeysha Clarke, Chrisann Kyi, Claire Friedman, Sandra D'Angelo, Mark G. Kris, Christopher A. Klebanoff, Ronak Shah, Michael Berger, Chaitanya Bandlamudi, Alexander Drilon, Mark T. Donoghue
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6570.
https://doi.org/10.1158/1538-7445.AM2024-6570
Published: 22 March 2024
View articletitled, Abstract 6570: HLA genotyping and HLA-based clinical trial matching using MSK-IMPACT, a targeted next-generation sequencing assay
Journal Articles

Abstract CT215: Efficacy and safety of adjuvant (adj) atezolizumab (atezo) from the Phase 2 LCMC3 study

David Paul Carbone, Saiama N. Waqar, Jamie E. Chaft, Mark G. Kris, Bruce E. Johnson, Jay M. Lee, Ignacio I. Wistuba, David Kwiatkowski, Paul Bunn, Katja Schulze, Ann Johnson, Evelise Brandao, Mark Awad, Karen L. Reckamp, Anne C. Chiang, Alan Nicholas, Valerie Rusch
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT215.
https://doi.org/10.1158/1538-7445.AM2023-CT215
Published: 14 April 2023
View articletitled, Abstract CT215: Efficacy and safety of adjuvant (adj) atezolizumab (atezo) from the Phase 2 LCMC3 study
Journal Articles

Abstract 1394: Comprehensive clinical and genomic analysis for patients with MYC, MYCN, and MYCL amplified solid tumors

Monica F. Chen, Allison Richards, Patrick Evans, Patrick Lee, Adam Price, Matteo Repetto, Soo Ryum Yang, Jason Chang, Rose Brannon, Ezra Rosen, David Brown, Charles Rudin, Nitya Raj, Mark G. Kris, Jorge Reis-Filho, Mark Donoghue, Alexander E. Drilon, Noura J. Choudhury
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1394.
https://doi.org/10.1158/1538-7445.AM2023-1394
Published: 04 April 2023
View articletitled, Abstract 1394: Comprehensive clinical and genomic analysis for patients with MYC, MYCN, and MYCL amplified solid tumors
Journal Articles

Abstract 610: Prospective genomic characterization of small cell lung cancer by targeted next generation sequencing

Helen H. Won, M. Catherine Pietanza, Lee M. Krug, Anna M. Varghese, Natasha Rekhtman, Lu Wang, William Travis, Paul K. Paik, Gregory J. Riely, Maureen F. Zakowski, Marc Ladanyi, Mark G. Kris, Charles M. Rudin, Michael F. Berger
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 610.
https://doi.org/10.1158/1538-7445.AM2015-610
Published: 01 August 2015
View articletitled, Abstract 610: Prospective genomic characterization of small cell lung cancer by targeted next generation sequencing
Journal Articles

Abstract CT225: Ado-trastuzumab emtansine for HER2 amplified or HER2 overexpressed cancers: A phase II “basket” trial

Bob T. Li, Marjorie Zauderer, Jamie Chaft, Alexander Drilon, Juliana Eng, Camelia Sima, Vicky Makker, Gopa Iyer, Yelena Janjigian, David Hyman, Maria Arcila, Jose Baselga, Mark G. Kris
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): CT225.
https://doi.org/10.1158/1538-7445.AM2015-CT225
Published: 01 August 2015
View articletitled, Abstract CT225: Ado-trastuzumab emtansine for HER2 amplified or HER2 overexpressed cancers: A phase II “basket” trial
Journal Articles

Abstract A29: Cooption of the reactive stroma by brain metastasis relies on protease inhibitors

Manuel Valiente, Derek J. Lee, Anna Obenauf, Jason T. Huse, Jamie E. Chaft, Mark G. Kris, Edi Brogi, Joan Massagué
Journal: Cancer Research
Cancer Res (2013) 73 (3_Supplement): A29.
https://doi.org/10.1158/1538-7445.TIM2013-A29
Published: 01 May 2014
View articletitled, Abstract A29: Cooption of the reactive stroma by brain metastasis relies on protease inhibitors
Journal Articles

Abstract 1784: Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations

Wee-Lee Yeo, Gregory J. Riely, Mark G. Kris, Daniel G. Tenen, William Pao, Susumu Kobayashi, Daniel B. Costa
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1784.
https://doi.org/10.1158/1538-7445.AM10-1784
Published: 15 April 2010
View articletitled, Abstract 1784: Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
Journal Articles

GM2, fucosyl GM1, globo H and polysialic acid are suitable targets for a tetravalent vaccine against SCLC

Philip Livingston, Chandra Hood, Lee M. Krug, Nyasha Warren, Mark G. Kris, Thomas Brezicka*, Govind Ragupathi
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1210–1211.
Published: 01 May 2005
View articletitled, GM2, fucosyl GM1, globo H and polysialic acid are suitable targets for a tetravalent vaccine against SCLC
Journal Articles

Pilot study of GD2 synthase transcript levels in small cell lung cancer (SCLC)

Lin-Chi Chen, Irene Y. Cheung, Jessica Jones, Mark G. Kris, Nai-Kong V. Cheung, Lee M. Krug
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 945.
Published: 01 May 2005
View articletitled, Pilot study of GD2 synthase transcript levels in small cell lung cancer (SCLC)
Journal Articles

Analysis of EGFR/PI3K signaling in bronchioloalveolar carcinoma progression and outcome

Inderpal S. Sarkaria, Duykhanh Pham, Simon G. Talbot, Michael Hezel, Kepal N. Patel, Michael I. Ebright, Maureen F. Zakowski, Shaokun Chuai, Natalie Memoli, Vincent A. Miller, Mark G. Kris, Valerie W. Rusch, Bhuvanesh Singh
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 442.
Published: 01 April 2004
View articletitled, Analysis of EGFR/PI3K signaling in bronchioloalveolar carcinoma progression and outcome
Journal Articles

Metabolic Phenotypes of Retinoic Acid and the Risk of Lung Cancer

James R. Rigas, Vincent A. Miller, Zuo-Feng Zhang, David S. Klimstra, William P. Tong, Mark G. Kris, Raymond P. Warrell, Jr.
Journal: Cancer Research
Cancer Res (1996) 56 (12): 2692–2696.
Published: 01 June 1996
View articletitled, Metabolic Phenotypes of Retinoic Acid and the Risk of Lung Cancer
Open the PDF for Metabolic Phenotypes of Retinoic Acid and the Risk of Lung Cancer in another window
Journal Articles

Phase I Clinical and Pharmacological Study of Chloroquinoxaline Sulfonamide

James R. Rigas, William P. Tong, Mark G. Kris, John P. Orazem, Charles W. Young, Raymond P. Warrell, Jr.
Journal: Cancer Research
Cancer Res (1992) 52 (23): 6619–6623.
Published: 01 December 1992
View articletitled, Phase I Clinical and Pharmacological Study of Chloroquinoxaline Sulfonamide
Open the PDF for Phase I Clinical and Pharmacological Study of Chloroquinoxaline Sulfonamide in another window
Journal Articles

Phase I Trial and Clinical Pharmacological Evaluation of 10-Ethyl-10-deazaaminopterin in Adult Patients with Advanced Cancer

Mark G. Kris, James J. Kinahan, Richard J. Gralla, Michael P. Fanucchi, Michael S. Wertheim, Joseph P. O'Connell, Linda D. Marks, Linda Williams, Fouad Farag, Charles W. Young, Francis M. Sirotnak
Journal: Cancer Research
Cancer Res (1988) 48 (19): 5573–5579.
Published: 01 October 1988
View articletitled, Phase I Trial and Clinical Pharmacological Evaluation of 10-Ethyl-10-deazaaminopterin in Adult Patients with Advanced Cancer
Open the PDF for Phase I Trial and Clinical Pharmacological Evaluation of 10-Ethyl-10-deazaaminopterin in Adult Patients with Advanced Cancer in another window